NCT05539430
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05539430
Title Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Legend Biotech USA Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
John Theurer Cancer Center at HackensackUMC Hackensack New Jersey 07601 United States Details
Roswell Park Comprehensive Cancer Center Buffalo New York 14263 United States Details
Duke University Durham North Carolina 27705 United States Details
OHSU Knight Cancer Institute Portland Oregon 97239 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 United States Details
Fred Hutchinson Cancer Center Seattle Washington 98109 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field